KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 161 filers reported holding KARUNA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,735,540 | -86.6% | 10,264 | -82.9% | 0.00% | -75.0% |
| Q2 2023 | $12,997,338 | +91.3% | 59,937 | +73.3% | 0.00% | +33.3% |
| Q4 2022 | $6,795,167 | -36.8% | 34,581 | -27.7% | 0.00% | -40.0% |
| Q3 2022 | $10,757,000 | +1941.2% | 47,824 | +1048.2% | 0.01% | – |
| Q2 2022 | $527,000 | -94.6% | 4,165 | -94.6% | 0.00% | -100.0% |
| Q1 2022 | $9,767,000 | +72.7% | 77,035 | +78.5% | 0.00% | +50.0% |
| Q4 2021 | $5,654,000 | +1185.0% | 43,158 | +1098.8% | 0.00% | – |
| Q3 2021 | $440,000 | -17.9% | 3,600 | -23.4% | 0.00% | – |
| Q2 2021 | $536,000 | -49.3% | 4,700 | -46.6% | 0.00% | – |
| Q1 2021 | $1,058,000 | -35.1% | 8,800 | -45.2% | 0.00% | – |
| Q4 2020 | $1,630,000 | +33.0% | 16,048 | +1.2% | 0.00% | -100.0% |
| Q3 2020 | $1,226,000 | -81.2% | 15,863 | -72.9% | 0.00% | -75.0% |
| Q2 2020 | $6,517,000 | +710.6% | 58,467 | +447.8% | 0.00% | +300.0% |
| Q4 2019 | $804,000 | – | 10,673 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
| Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
| Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
| Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
| DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
| First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
| Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
| ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |
| Logos Global Management LP | 100,000 | $18,164,000 | 2.60% |